Concepcion Maranon
Overview
Explore the profile of Concepcion Maranon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
789
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Prado A, Cal-Sabater P, Fiz-Lopez A, Izquierdo S, Corrales D, Perez-Cozar F, et al.
Sci Rep
. 2024 Nov;
14(1):28685.
PMID: 39562636
The immune cellular landscape from the gastric mucosa remains largely unknown despite its relevance in several inflammatory conditions. Human gastric biopsies were obtained from the antrum, body and incisura from...
2.
Castellini-Perez O, Povedano E, Barturen G, Martinez-Bueno M, Iakovliev A, Kerick M, et al.
NPJ Genom Med
. 2024 Jul;
9(1):38.
PMID: 39013887
The heterogeneity of systemic lupus erythematosus (SLE) can be explained by epigenetic alterations that disrupt transcriptional programs mediating environmental and genetic risk. This study evaluated the epigenetic contribution to SLE...
3.
Rybakowska P, Alarcon-Riquelme M, Maranon C
Methods Mol Biol
. 2024 Mar;
2779:369-394.
PMID: 38526795
Clinical studies are conducted to better understand the pathological mechanism of diseases and to find biomarkers associated with disease activity, drug response, or outcome prediction. Mass cytometry (MC) is a...
4.
Lopez-Dominguez R, Villatoro-Garcia J, Maranon C, Goldman D, Petri M, Carmona-Saez P, et al.
Res Sq
. 2024 Jan;
PMID: 38260685
Lupus nephritis (LN) represents one of the most severe complications of systemic lupus erythematosus, leading to end-stage kidney disease in worst cases. Current first-line therapies for LN, including mycophenolate mofetil...
5.
Courel-Ibanez J, Vetrovsky T, Ruzickova N, Maranon C, Durkalec-Michalski K, Tomcik M, et al.
Rheumatol Int
. 2024 Jan;
44(3):413-423.
PMID: 38180500
There is increasing knowledge in the recognition of individuals at risk for progression to rheumatoid arthritis (RA) before the clinical manifestation of the disease. This prodromal phase preceding the manifestation...
6.
Van Breedam E, Buyle-Huybrecht T, Govaerts J, Meysman P, Bours A, Boeren M, et al.
Front Immunol
. 2023 Jun;
14:1177245.
PMID: 37287975
With Varicella-Zoster Virus (VZV) being an exclusive human pathogen, human induced pluripotent stem cell (hiPSC)-derived neural cell culture models are an emerging tool to investigate VZV neuro-immune interactions. Using a...
7.
Guzman-Martinez G, Maranon C
Front Immunol
. 2022 Nov;
13:974826.
PMID: 36420265
Systemic lupus erythematosus (SLE) patients display an increased risk of cardiovascular disease (CVD). With the improved clinical management of other classical severe manifestation of the disease, CVD is becoming one...
8.
Rybakowska P, Van Gassen S, Martorell Marugan J, Quintelier K, Saeys Y, Alarcon-Riquelme M, et al.
STAR Protoc
. 2022 Nov;
3(4):101697.
PMID: 36353363
Mass cytometry (MC) is a powerful large-scale immune monitoring technology. To maximize MC data quality, we present a protocol for whole blood analysis together with an R package, Cyto Quality...
9.
Maldonado-Perez N, Tristan-Manzano M, Justicia-Lirio P, Martinez-Planes E, Munoz P, Pavlovic K, et al.
Front Immunol
. 2022 Oct;
13:1011858.
PMID: 36275777
Autologous T cells expressing the Chimeric Antigen Receptor (CAR) have been approved as advanced therapy medicinal products (ATMPs) against several hematological malignancies. However, the generation of patient-specific CAR-T products delays...
10.
Tristan-Manzano M, Maldonado-Perez N, Justicia-Lirio P, Munoz P, Cortijo-Gutierrez M, Pavlovic K, et al.
Mol Ther Oncolytics
. 2022 Aug;
26:245.
PMID: 35919458
[This corrects the article DOI: 10.1016/j.omto.2022.05.003.].